| Literature DB >> 33392827 |
Heng Zhai1, Yinzhang Lv2, Yu Xu1, Yi Wu1, Weiqi Zeng1, Tao Wang3, Xuebing Cao4, Yan Xu5.
Abstract
Information about Parkinson's disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 (p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death.Entities:
Keywords: COVID-19; Clinical characteristics; Clinical outcomes; Parkinson’s disease; SARS-CoV-2
Mesh:
Year: 2021 PMID: 33392827 PMCID: PMC7779096 DOI: 10.1007/s00702-020-02283-y
Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN: 0300-9564 Impact factor: 3.575